Stock overview
Biomarin Pharmaceutical Inc.
Explore the company, reported ownership, price history, and available source evidence.
BIOMARIN PHARMACEUTICAL INC (BMRN) is a healthcare or biotechnology equity security tracked from 13F filings.
- Last close
- $60.26
- · BMRN
- Tracked holders
- 3 funds
- Latest available 13F per fund
BMRN · USD
Price
$60.26
-$18.36
(-23.35%)
over selected range
Close · Sep 25, 2026
Market closed
1255 stored daily closes
$60.26
Sep 25, 2026
- Range low
- $49.67
- Range high
- $117.27
- Observations
- 1255
- Session date
- Sep 25, 2026
Sep 27, 2021–Sep 25, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Viking Global Investors largest tracked holder Q2 2026 · filed Aug 14, 2026 · SEC filing | +8% 26'Q2 | $435,819,735 | 1.24% |
| Renaissance Technologies position history Q2 2026 · filed Aug 13, 2026 · SEC filing | −56% 26'Q2 | $25,856,059 | 0.04% |
| Gotham Asset Management position history Q2 2026 · filed Aug 14, 2026 · SEC filing | −84% 26'Q2 | $1,638,838 | 0% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market